http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103804498-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 |
| filingDate | 2013-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103804498-B |
| titleOfInvention | Long-acting restructuring chorionic gonadotrophin and application thereof |
| abstract | Do you the invention discloses recombinant human chorionic gonadotrophin fusion rotein (Human? chorionic? gonadotrophin-Fc? fusion? protein, be called for short HCG-Fc) and preparation method thereof, this HCG-Fc albumen is dimeric fusion protein, does its aminoacid sequence hold C end to comprise HCG β subunit, HCG α subunit, flexible peptide linker and human IgG successively from N? Fc variant, compared with existing chorionic gonadotrophin, its Half-life in vivo is longer, bioavailability is higher, can greatly reduce times for spraying and dosage.The invention still further relates to restructuring HCG-Fc fusion protein compositions and prepare the purposes in animal reproduction field of medicament. |
| priorityDate | 2013-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 218.